MBX Biosciences (MBX) Times Interest Earned (2023 - 2026)
MBX Biosciences (MBX) posted Times Interest Earned of -$0.35 for Q1 2026, up 99.87% sequentially from -$257.95 in Q4 2025, and up 95.87% YoY from -$0.18 in Q1 2025.
MBX Biosciences (MBX) Times Interest Earned (2023 - 2026) Analysis & Trends
MBX Biosciences has reported Times Interest Earned for 4 years, with the latest figure at -$0.35 in Q1 2026.
- Quarterly Times Interest Earned rose 95.87% year-over-year to -$0.35 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.26 (up 95.12% YoY) and the FY2025 annual result came in at -$1.0, up 39.02% from the prior year.
- Times Interest Earned climbed to -$0.35 in Q1 2026 per MBX's latest filing, from -$257.95 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.35 in Q1 2026 and troughed at -$257.95 in Q4 2025.
- A 4-year average of -$84.11 and a median of -$8.4 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned plunged 8362.14% in 2024, then surged 98.99% in 2025.
- Over 4 years, Times Interest Earned stood at -$2.2 in 2023, then slumped by 8362.14% to -$186.1 in 2024, then plunged by 38.61% to -$257.95 in 2025, then surged by 99.87% to -$0.35 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.35, -$257.95, and -$0.63 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | MBX Biosciences | 3.29 Bn | 3.29 Bn | - | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.22 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -257.95 |
| Sep 30, 2025 | -0.63 |
| Jun 30, 2025 | -1.69 |
| Mar 31, 2025 | -8.40 |
| Dec 31, 2024 | -186.10 |
| Jun 30, 2024 | -166.58 |
| Mar 31, 2024 | -133.14 |
| Dec 31, 2023 | -2.20 |